Evidence map›Paper›PMID 30171222›Full record

ArticleBone marrow transplantation2019

High-dose Benda-EAM versus BEAM in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplantation.

Erica S Tsang, Diego Villa, Federica Loscocco, Giuseppe Visani, Maryse Power, Barbara Guiducci, Cristina Clissa, Kevin Song, Cynthia Toze, Yasser Abou Mourad and 9 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Erica S TsangDepartment of Medicine, University of British Columbia, Vancouver, Canada.
Diego VillaCentre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer, Vancouver, Canada. dvilla@bccancer.bc.ca.ORCID 0000-0002-4625-3009
Federica LoscoccoHematology and Stem Cell Transplant Center, AORMN, Pesaro, Italy.
Giuseppe VisaniHematology and Stem Cell Transplant Center, AORMN, Pesaro, Italy.
Maryse PowerLeukemia/Bone Marrow Transplant Program of British Columbia and Division of Hematology, Vancouver General Hospital and BC Cancer, Vancouver, Canada.
Barbara GuiducciHematology and Stem Cell Transplant Center, AORMN, Pesaro, Italy.
Cristina ClissaHematology and Stem Cell Transplant Center, AORMN, Pesaro, Italy.
Kevin SongLeukemia/Bone Marrow Transplant Program of British Columbia and Division of Hematology, Vancouver General Hospital and BC Cancer, Vancouver, Canada.
Cynthia TozeLeukemia/Bone Marrow Transplant Program of British Columbia and Division of Hematology, Vancouver General Hospital and BC Cancer, Vancouver, Canada.
Yasser Abou MouradLeukemia/Bone Marrow Transplant Program of British Columbia and Division of Hematology, Vancouver General Hospital and BC Cancer, Vancouver, Canada.
Heather SutherlandLeukemia/Bone Marrow Transplant Program of British Columbia and Division of Hematology, Vancouver General Hospital and BC Cancer, Vancouver, Canada.
David SanfordLeukemia/Bone Marrow Transplant Program of British Columbia and Division of Hematology, Vancouver General Hospital and BC Cancer, Vancouver, Canada.
Stephen H NantelLeukemia/Bone Marrow Transplant Program of British Columbia and Division of Hematology, Vancouver General Hospital and BC Cancer, Vancouver, Canada.
Laurie H SehnCentre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer, Vancouver, Canada.
David W ScottCentre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer, Vancouver, Canada.
Kerry J SavageCentre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer, Vancouver, Canada.
Joseph M ConnorsCentre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer, Vancouver, Canada.
Alina S GerrieCentre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer, Vancouver, Canada.
Alessandro IsidoriHematology and Stem Cell Transplant Center, AORMN, Pesaro, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAgedAntineoplastic Combined Chemotherapy ProtocolsCarmustineCytarabineEtoposideFemaleHematopoietic Stem Cell TransplantationHodgkin DiseaseHumansMaleMelphalanMiddle AgedRecurrenceTransplantation, AutologousCarmustineCytarabineEtoposideMelphalan

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.